SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer
— Novel Vaccine Company Expands Leadership Team and Establishes US Presence — Oxford, UK and Cambridge, MA (July 11, 2022) — SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive Officer (CEO). He also joins the